05 May 2015 : Laboratory Research
Gene Expression Changes in Residual Advanced Cervical Cancer after Radiotherapy: Indicators of Poor Prognosis and Radioresistance?
Zhi-chao FuBC, Feng-mei WangA, Jian-ming CaiAGDOI: 10.12659/MSM.893689
Med Sci Monit 2015; 21:1276-1287
Abstract
BACKGROUND: Different sensitivity of advanced cervical cancer to irradiation can decrease effectiveness of radiotherapy in some cases. We attempted to identify the differentially expressed genes in residual cervical cancer after radiotherapy that might be associated with poor prognosis and radioresistance.
MATERIAL AND METHODS: Differential genes expression was identified by an oligonucleotide microarray in cervical cancer tissues before radiation and after a 50-Gy dose of radiation. The microarray results were validated by quantitative real-time PCR. CXCL12 was validated by immunohistochemistry in paraffin-embedded cervical cancer tissues before radiotherapy. The relationship between the differentiated gene and prognosis was validated by survival analysis.
RESULTS: Hierarchic cluster analysis identified 238 differentiated genes that exhibited ≥3.0-fold change and p<0.05. We found 111 genes that were in persistent up-regulation and 127 in persistent down-regulation after a 50-Gy dose of radiation when compared with the control group. These genes were involved in processes such as cell growth and death, cell-apoptosis, cell cycle regulation, cell signaling, DNA synthesis and repair, and cell adhesion. High differential expression of CXCL12, CD74, FGF7, COL14A1, PRC1, and RAD54L genes was validated by quantitative PCR before and after radiotherapy. Survival analysis results showed that the high expression of CXCL12 was closely related to poor prognosis.
CONCLUSIONS: The higher expression of CXCL12 might be informative regarding poor prognosis in patients undergoing radical radiotherapy. The differentially expressed genes identified in our study might provide a new method for diagnosis and treatment of radioresistance in cervical cancer.
Keywords: Carcinoma, Squamous Cell - radiotherapy, Chemokine CXCL12 - genetics, Cluster Analysis, Neoplasm Proteins - genetics, Oligonucleotide Array Sequence Analysis, Radiation Tolerance, Radiotherapy Dosage, Real-Time Polymerase Chain Reaction, Uterine Cervical Neoplasms - radiotherapy
Editorial
01 September 2024 : Editorial
Editorial: Reasons for Increasing Global Concerns for the Spread of MpoxDOI: 10.12659/MSM.946343
Med Sci Monit 2024; 30:e946343
In Press
Laboratory Research
Three-Dimensional Optical Study on the Effects of Microwave Glazing on Surface Roughness of Zirconia-Reinfo...Med Sci Monit In Press; DOI: 10.12659/MSM.945130
Clinical Research
Prognostic Significance of the Advanced Lung Cancer Inflammation Index in Metastatic Small Cell Lung Cancer...Med Sci Monit In Press; DOI: 10.12659/MSM.945752
Review article
Dangerous Intersection of Alcoholism and Othello Syndrome: A Comprehensive Review of Delusional Jealousy an...Med Sci Monit In Press; DOI: 10.12659/MSM.945616
Clinical Research
Intrathecal Morphine Enhances Postoperative Analgesia and Recovery in Robotic-Assisted Laparoscopic Partial...Med Sci Monit In Press; DOI: 10.12659/MSM.945595
Most Viewed Current Articles
17 Jan 2024 : Review article 6,040,263
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,829,664
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 692,760
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,212
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074